NEWS: HHS and DeptofDefense have announced an agreement with JNJNews for manufacture and delivery of the company's COVID19 vaccine candidate. Under the terms, the federal government will own the resulting 100 million doses of vaccine.
Under the terms of the agreement, the federal government will own the resulting 100 million doses of vaccine.
This manufacturing demonstration project will take place while clinical trials are underway. Working in parallel this way expedites the traditional vaccine development timeline. This step builds toward the U.S. government's The Biomedical Advanced Research and Development Authority , part of the HHS Office of the Assistant Secretary for Preparedness and Response, collaborated with the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense and Army Contracting Command, to provide approximately $1 billion to support the manufacturing demonstration project including the ability to deliver vaccine doses to government-designated locations across the country.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. HHS says Secretary Azar to lead delegation to TaiwanU.S. Department of Health and Human Services (HHS) Secretary Alex Azar will lead a delegation to Taiwan in the coming days, the highest level visit by a U.S. Cabinet official since 1979, the department said on Tuesday.
Read more »
U.S. to pay over $1 billion for 100 million doses of Johnson & Johnson's potential COVID-19 vaccineThe United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its potential coronavirus vaccine, its latest such arrangement as the race to tame the pandemic intensifies, the drugmaker said on Wednesday.
Read more »
Brazil, hotbed for COVID-19 vaccine testing, may struggle to produce its ownBrazilian officials say they can start making COVID-19 vaccines developed by British and Chinese researchers within a year. Experts say it will take at least twice as long, leaving Brazil reliant on imports to slow the world's second-worst outbreak.
Read more »
Novavax coronavirus vaccine induces immune response in small studyMaryland-based biotechnology company Novavax said its experimental COVID-19 vaccine produced antibodies against the novel coronavirus and appears to be safe, according to an early stage study
Read more »